Cosentyx 300 MG dose-2 syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F5T8L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,900
Award facts
- Contract value 100% obligated
- $21,900.14 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,900.14 to AmerisourceBergen Drug Corp for 2 syringes of Cosentyx 300 mg dose on November 25, 2025. This is a firm fixed price delivery order with no set-aside designation, with performance scheduled in Conshohocken, Pennsylvania and an ultimate completion date of November 26, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key provider within DLA's pharmaceutical procurement strategy.
Quick answers
Who was awarded contract SPE2DR26F5T8L?
SPE2DR26F5T8L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F5T8L worth?
The government has obligated $21,900 on SPE2DR26F5T8L.
Is contract SPE2DR26F5T8L an order under another contract?
Yes. SPE2DR26F5T8L is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5T8L competed?
The extent of competition for SPE2DR26F5T8L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award